Comparison of clinical variables and scintigraphic results between patients who did or did not receive thrombolytic treatment
| Variable | No thrombolytic treatment (n=108) | Thrombolytic treatment (n=92) |
|---|---|---|
| Age (years (SD)) | 59 (11) | 57 (10) |
| Male (n (%)) | 88 (81) | 80 (87) |
| Past AMI (n (%)) | 21 (19) | 12 (13) |
| Chronic angina (n (%)) | 15 (14) | 14 (15) |
| Past CABG/PTCA (n (%)) | 10 (9) | 4 (4) |
| Hypertension (n (%)) | 47 (43) | 30 (33) |
| Diabetes mellitus (n (%)) | 9 (8) | 7 (8) |
| Current smoker (n (%)) | 36 (33) | 47 (51)* |
| Anterior MI (n (%)) | 41 (38) | 32 (35) |
| Non-Q wave MI (n (%)) | 48 (44) | 21 (23)† |
| Peak CK level (units/l (SD)) | 1208 (981) | 2452 (1592)‡ |
| LVEF% (n=195) (SD) | 50% (11) | 54% (11)§ |
| Infarct zone Tl redistribution (n (%)) | 61 (56) | 50 (54) |
| Non-infarct zone Tl redistribution (n (%)) | 25 (23) | 15 (16) |
| Number segments with Tl redistribution (SD) | 1.8 (1.7) | 1.5 (1.6) |
| > 2 segments with Tl redistribution (n (%)) | 35 (32) | 28 (30) |
(A)MI, (acute) myocardial infarction; CABG, coronary artery bypass grafting; CK, creatine kinase; LVEF, left ventricular ejection fraction; PTCA, percutaneous transluminal coronary angioplasty; Tl, thallium-201.
Patients not given v those given thrombolytic treatment:*p = 0.02; †p = 0.002; ‡p< 0.001; §p=0.008.